Tag: drug trade names


DEXEDRINE

Introduction and Nomenclature The name Dexedrine is the registered trade name for the pharmaceutical compound dextroamphetamine sulfate, a potent central nervous system (CNS) stimulant belonging to the phenethylamine and substituted amphetamine classes. Chemically, dextroamphetamine is the dextrorotatory (D-) enantiomer of the amphetamine molecule. This specific isomer is significantly more pharmacologically active in terms of CNS […]

Read More

ANTILIRIUM

Introduction and Definition of Antilirium The term Antilirium designates the major trade name historically associated with the pharmaceutical compound physostigmine salicylate. Derived from the alkaloid physostigmine, this medication is fundamentally classified as a reversible cholinesterase inhibitor. In clinical practice, the recognition of the name Antilirium immediately signifies the presence of physostigmine, a substance critical for […]

Read More

AVENTYL

Introduction and Definition of Aventyl Aventyl is a widely recognized brand name for the pharmaceutical compound nortriptyline hydrochloride, a potent agent classified within the category of tricyclic antidepressants (TCAs). This medication has maintained a significant role in psychopharmacology since its introduction, primarily indicated for the treatment of Major Depressive Disorder (MDD). Nortriptyline is specifically characterized […]

Read More

AQUACHLORAL

Introduction and Nomenclature of Aquachloral The substance known by the trade name Aquachloral is fundamentally defined as a proprietary designation for the well-established pharmaceutical compound chloral hydrate. As a widely recognized, though somewhat antiquated, sedative-hypnotic drug, chloral hydrate holds a significant place in the history of psychoactive medication, being one of the oldest synthetic central […]

Read More

SINEMET

Introduction to Sinemet and its Composition Sinemet is the widely recognized trade name for a combination pharmaceutical agent crucial in the management of Parkinson’s disease (PD), a chronic and progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra. This specific formulation combines two essential components: levodopa (L-DOPA), the metabolic precursor […]

Read More